Literature DB >> 18284853

Innate immunity in the paranasal sinuses: a review of nasal host defenses.

Eng Hooi Ooi1, Peter-John Wormald, Lor Wai Tan.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is a common inflammatory disorder of the paranasal sinuses. An abnormal host response to common bacterial or fungal pathogens is thought to be an important factor in the disease process. Host sinonasal epithelium plays an important role in initially recognizing the presence of microbes and responding by increasing production of antimicrobial peptides and cytokines, with recruitment of phagocytes and lymphocytes of the adaptive immune system, to eliminate the infection. Recently, the innate immune system and its complex interplay with the adaptive immune system are increasingly being recognized as important in the pathogenesis of chronic inflammatory diseases such as asthma and CRS.
METHODS: Review of recent findings on innate immunity in the pathogenesis of CRS.
RESULTS: New areas of research into potentially novel therapies for CRS are highlighted in this review, with emphasis on toll-like receptors, antimicrobial peptides (cathelicidins and defensins), and surfactant proteins.
CONCLUSION: This review provides an overview of innate immunity in the sinonasal tract and discusses potential use of innate immune peptides as treatments against fungi, biofilms, and superantigens in CRS.

Entities:  

Mesh:

Year:  2008        PMID: 18284853     DOI: 10.2500/ajr.2008.22.3127

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  38 in total

Review 1.  Bitter and sweet taste receptors in the respiratory epithelium in health and disease.

Authors:  Robert J Lee; Noam A Cohen
Journal:  J Mol Med (Berl)       Date:  2014-11-13       Impact factor: 4.599

2.  Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis.

Authors:  Jivianne T Lee; Mike Jansen; Abebayehu N Yilma; Angels Nguyen; Robert Desharnais; Edith Porter
Journal:  Am J Rhinol Allergy       Date:  2010 Mar-Apr       Impact factor: 2.467

3.  Nasal microenvironments and interspecific interactions influence nasal microbiota complexity and S. aureus carriage.

Authors:  Miling Yan; Sünje J Pamp; Julia Fukuyama; Peter H Hwang; Do-Yeon Cho; Susan Holmes; David A Relman
Journal:  Cell Host Microbe       Date:  2013-12-11       Impact factor: 21.023

4.  Novel role of surfactant protein A in bacterial sinusitis.

Authors:  George T Noutsios; Amanda L Willis; Julie G Ledford; Eugene H Chang
Journal:  Int Forum Allergy Rhinol       Date:  2017-07-20       Impact factor: 3.858

5.  Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components.

Authors:  Robert J Lee; Bei Chen; Kevin M Redding; Robert F Margolskee; Noam A Cohen
Journal:  Innate Immun       Date:  2013-09-17       Impact factor: 2.680

Review 6.  The Role of Bitter and Sweet Taste Receptors in Upper Airway Immunity.

Authors:  Alan D Workman; James N Palmer; Nithin D Adappa; Noam A Cohen
Journal:  Curr Allergy Asthma Rep       Date:  2015-12       Impact factor: 4.806

Review 7.  Chronic rhinosinusitis pathogenesis.

Authors:  Whitney W Stevens; Robert J Lee; Robert P Schleimer; Noam A Cohen
Journal:  J Allergy Clin Immunol       Date:  2015-12       Impact factor: 10.793

Review 8.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

Review 9.  Clinical and laboratory evidence for Neisseria meningitidis biofilms.

Authors:  R Brock Neil; Michael A Apicella
Journal:  Future Microbiol       Date:  2009-06       Impact factor: 3.165

Review 10.  A role for airway taste receptor modulation in the treatment of upper respiratory infections.

Authors:  Jennifer E Douglas; Cecil J Saunders; Danielle R Reed; Noam A Cohen
Journal:  Expert Rev Respir Med       Date:  2016-01-22       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.